Li Zhiwei, Liu Mengmeng, Chen Bowang, Wu Yuelin, Jia Hui, Geng Ruirui, Wang Yixiao, Zhang Xiaoyan, Yang Yang, Cui Jianlan, Lu Jiapeng, Guo Zhiping, Li Xi, Zhang Weili
National Clinical Research Center of Cardiovascular Diseases, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, Beijing, 100037, People's Republic of China.
Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central-China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, 450000, People's Republic of China.
BMC Med. 2025 Apr 16;23(1):226. doi: 10.1186/s12916-025-04055-5.
The relationship between high-normal blood pressure (BP) and mortality lacks high-quality evidence based on large population cohorts. This study aims to comprehensively investigate the association of high-normal BP and its trajectory with all-cause and cause-specific mortality.
In this community-based population cohort from the China Health Evaluation And risk Reduction Through nationwide teamwork (ChinaHEART) project, 3,598,940 participants aged 35-75 years with data for baseline BP were included. High-normal BP was defined as a systolic BP (SBP) of 130-139 mmHg and/or a diastolic BP (DBP) of 85-89 mmHg at baseline. Overall, 78,130 participants with three or more BP measurements were included in the trajectory pattern analysis during the follow-up. Four BP change trajectory patterns were identified.
For the baseline BP analysis, compared with the optimal BP group (SBP < 120 mmHg and DBP < 80 mmHg [18.1%]), participants with high-normal BP (18.7%) had an increase of 4% in all-cause mortality risk (hazard ratio [HR] 1.04, 95% confidence interval [CI] 1.01-1.07) and an increase of 28% in cardiovascular disease (CVD) mortality risk (HR 1.28, 95% CI 1.21-1.34), with the greatest increase in mortality risk observed for hemorrhagic stroke (HR 1.75, 95% CI 1.55-1.98). Among the BP trajectory patterns, compared with participants with optimal-stable BP, those with high-normal-increasing BP had an increase of 35% in all-cause mortality risk (HR 1.35, 95% CI 1.07-1.70) and an increase in CVD mortality risk of 57% (HR 1.57, 95% CI 1.11-2.24), with the greatest increase in mortality risk also observed for hemorrhagic stroke (HR 3.75, 95% CI 1.50-9.34). Approximately 0.7% and 1.6% of all-cause mortality was attributable to high-normal BP at baseline and the high-normal-increasing BP trajectory pattern, respectively.
Individuals with high-normal BP at baseline exhibited a significantly elevated mortality risk and especially for risk of hemorrhagic stroke mortality during the follow-up. This positive association may be mainly attributed to the "high-normal-increasing" BP change over time.
基于大规模人群队列研究,关于血压略高于正常范围(高正常血压)与死亡率之间的关系缺乏高质量证据。本研究旨在全面调查高正常血压及其变化轨迹与全因死亡率和特定病因死亡率之间的关联。
在中国心脏健康评估与全国团队合作降低风险(ChinaHEART)项目的这个基于社区的人群队列研究中,纳入了35 - 75岁有基线血压数据的3,598,940名参与者。高正常血压在基线时定义为收缩压(SBP)130 - 139 mmHg和/或舒张压(DBP)85 - 89 mmHg。总体而言,随访期间有78,130名进行了三次或更多次血压测量的参与者被纳入轨迹模式分析。确定了四种血压变化轨迹模式。
对于基线血压分析,与最佳血压组(SBP<120 mmHg且DBP<80 mmHg [18.1%])相比,高正常血压组(18.7%)的参与者全因死亡风险增加了4%(风险比[HR] 1.04,95%置信区间[CI] 1.01 - 1.07),心血管疾病(CVD)死亡风险增加了28%(HR 1.28,95% CI 1.21 - 1.34),其中出血性卒中的死亡风险增加最为显著(HR 1.75,95% CI 1.55 - 1.98)。在血压轨迹模式中,与最佳稳定血压的参与者相比,高正常血压且上升的参与者全因死亡风险增加了35%(HR 1.35,95% CI 1.07 - 1.70),CVD死亡风险增加了57%(HR 1.57,95% CI 1.11 - 2.24),出血性卒中的死亡风险增加也最为显著(HR 3.75,95% CI 1.50 - 9.34)。分别约0.7%和1.6%的全因死亡可归因于基线时的高正常血压和高正常血压且上升的轨迹模式。
基线时血压略高于正常范围的个体在随访期间表现出显著升高的死亡风险,尤其是出血性卒中死亡风险。这种正相关可能主要归因于血压随时间“高正常且上升”的变化。